These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

70 related items for PubMed ID: 1883745

  • 1. Epithelial cell type, clinical behaviour and AgNOR counts in thymic epithelial tumours.
    Rahilly MA, Edwards CW, Crocker J, Murray P.
    Anal Cell Pathol; 1991 Jul; 3(4):203-13. PubMed ID: 1883745
    [Abstract] [Full Text] [Related]

  • 2. Pathological aspects of malignant and benign thymic disorders.
    Müller-Hermelink HK, Marx A.
    Ann Med; 1999 Oct; 31 Suppl 2():5-14. PubMed ID: 10574149
    [Abstract] [Full Text] [Related]

  • 3. Argyrophilic nucleolar organizer regions in cells of thymoma and thymic carcinoma: correlation with DNA ploidy and clinicopathologic characteristics.
    Lee YC, Chern JH, Pan CC, Chang SC, Perng RP.
    Chest; 1999 Apr; 115(4):1115-9. PubMed ID: 10208217
    [Abstract] [Full Text] [Related]

  • 4. Well-differentiated thymic carcinoma. An organotypical low-grade carcinoma with relationship to cortical thymoma.
    Kirchner T, Schalke B, Buchwald J, Ritter M, Marx A, Müller-Hermelink HK.
    Am J Surg Pathol; 1992 Dec; 16(12):1153-69. PubMed ID: 1463094
    [Abstract] [Full Text] [Related]

  • 5. Thymic epithelial tumours: evaluation of malignant grade by quantification of proliferating cell nuclear antigen and nucleolar organizer regions.
    Tateyama H, Mizuno T, Tada T, Eimoto T, Hashimoto T, Masaoka A.
    Virchows Arch A Pathol Anat Histopathol; 1993 Dec; 422(4):265-9. PubMed ID: 8099456
    [Abstract] [Full Text] [Related]

  • 6. Histopatholgical spectrum of thymic neoplasms: twelve-year experience at a referral hospital in north India.
    Radotra B, Awasthi A, Joshi K, Das A.
    Indian J Pathol Microbiol; 2006 Jan; 49(1):1-6. PubMed ID: 16625962
    [Abstract] [Full Text] [Related]

  • 7. Argyrophilic nucleolar organizer region counts predict survival in thymoma.
    Pich A, Chiarle R, Chiusa L, Palestro G.
    Cancer; 1994 Sep 01; 74(5):1568-74. PubMed ID: 7520349
    [Abstract] [Full Text] [Related]

  • 8. Epithelial thymus tumors--therapy and prognosis.
    Elert O, Buchwald J, Wolf K.
    Thorac Cardiovasc Surg; 1988 Apr 01; 36(2):109-13. PubMed ID: 3388401
    [Abstract] [Full Text] [Related]

  • 9. Clinicopathological study of thymomas--correlation of histologic subtype to myasthenia gravis and prognosis.
    Sundaram C, Rajagopal P, Rakshak AD, Omprakash G, Das SM, Murthy JM.
    Indian J Pathol Microbiol; 2003 Jul 01; 46(3):378-81. PubMed ID: 15025278
    [Abstract] [Full Text] [Related]

  • 10. [Morphometrical and immunohistochemical analysis of cortical and medullary thymoma: its correlation with invasiveness and association with myasthenia gravis].
    Nomori H, Ishihara T, Torikata C.
    Nihon Kyobu Geka Gakkai Zasshi; 1990 Jan 01; 38(1):93-100. PubMed ID: 1691772
    [Abstract] [Full Text] [Related]

  • 11. Thymomas and thymic carcinomas. Evaluation of the Müller-Hermelink classification.
    Papla B, Rudnicka L, Dubiel-Bigaj M, Malinowski E.
    Pol J Pathol; 1998 Jan 01; 49(4):251-65. PubMed ID: 10323079
    [Abstract] [Full Text] [Related]

  • 12. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
    Pich A, Chiusa L, Margaria E.
    Cancer Detect Prev; 1995 Jan 01; 19(3):282-91. PubMed ID: 7750118
    [Abstract] [Full Text] [Related]

  • 13. Adenoid cystic carcinoma: a study of nucleolar organizer regions (AgNOR) counts and their relation to prognosis.
    Fonseca I, Soares J.
    J Pathol; 1993 Feb 01; 169(2):255-8. PubMed ID: 8383198
    [Abstract] [Full Text] [Related]

  • 14. Thymoma: a pathological study of 50 cases.
    Vaideeswar P, Padmanabhan A, Deshpande JR, Pandit SP.
    J Postgrad Med; 2004 Feb 01; 50(2):94-7. PubMed ID: 15235201
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of prognostic features in thymic epithelial tumors.
    Kirchner T, Schalke B, Marx A, Müller-Hermelink HK.
    Thymus; 1989 Feb 01; 14(1-3):195-203. PubMed ID: 2623740
    [Abstract] [Full Text] [Related]

  • 16. Nucleolar organiser regions and morphologic subtypes of squamous cell carcinoma of cervix.
    Kashyap S, Kapila K, Kumar N, Kinra G, Rath GK, Verma K.
    Indian J Pathol Microbiol; 1998 Jul 01; 41(3):303-8. PubMed ID: 9805852
    [Abstract] [Full Text] [Related]

  • 17. B-cells in thymic epithelial tumours. An immunohistochemical analysis of intra- and extraepithelial B-cell compartments.
    Fend F, Kirchner T, Marx A, Müller-Hermelink HK.
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1993 Jul 01; 63(4):241-7. PubMed ID: 7685134
    [Abstract] [Full Text] [Related]

  • 18. AgNOR distribution in serous tumours of the ovary.
    Mauri FA, Scampini S, Aldovini D, Ferrero S, Barbareschi M, Dalla Palma P.
    Pathologica; 1990 Jul 01; 82(1081):487-92. PubMed ID: 1706828
    [Abstract] [Full Text] [Related]

  • 19. Acinic cell carcinomas of salivary glands histoprognosis. Value of NORs stained with AgNOR technique and examined with semi-automatic image analysis.
    Chomette G, Auriol M, Wann A, Guilbert F.
    J Biol Buccale; 1991 Sep 01; 19(3):205-10. PubMed ID: 1718956
    [Abstract] [Full Text] [Related]

  • 20. Activation of STAT3 in thymic epithelial tumours correlates with tumour type and clinical behaviour.
    Chang KC, Wu MH, Jones D, Chen FF, Tseng YL.
    J Pathol; 2006 Oct 01; 210(2):224-33. PubMed ID: 16917804
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.